Question
Answer 1. The exact sample size (n) for each experimental group/condition (as a number, not a range). Include details of a power analysis if done, or any other relevant considerations that determined the choice of sample size. For n < 6, individual data values should be shown rather than summary statistics alone. 2. A description of sample collection that enables the reader to understand whether the samples represent technical or biological replicates, and an explanation of inclusion/exclusion criteria if samples or organisms were excluded from the analysis. 3. How samples/ organisms were allocated to experimental groups and processed, and full details of the randomisation procedure used (if relevant). 4. For sample assessment by human investigators, a statement on whether the investigator was blinded to group assignment and outcome assessment, and how this blinding was achieved and evaluated (if relevant). Cutoff points of 44 (total coarse points) and 55 (standard score) were used to define depression for the Self-Rating Depression Scale (SDS), whereas a score of 5 or more was used as a cutoff to define depression for patient health questionnaire 9 (PHQ9).
Irrelevant
Irrelevant 5. How many times each experiment shown was replicated and an indication of the extent of variation from experiment to experiment. 6. Information on the statistical methods and measures used. It should be clear whether the tests are one-sided or two-sided, whether there are adjustments for multiple comparisons, whether medians or means are being shown, whether error bars are standard deviations (SD), standard error of mean (SEM) or confidence intervals. 7. A justification for the appropriateness of statistical tests used to assess significance. Do the data meet the assumptions of the tests? Is there an estimate of variation within each group of data, and is the variance similar between groups that are being statistically compared? In addition, information essential to interpreting the data presented should be made available in the figure and table legends. If the study involves health interventions for human participants, please refer to the relevant reporting guidelines from the EQUATOR Network, and the Biosharing Portal for reporting checklists for biological and biomedical research, where applicable.
Research involving humans
If your research involved humans, please confirm you have adhered to the relevant reporting guideline from the EQUATOR Network, and included the completed checklist as an additional file with your submission:
Answer (page and line number inserted/Not applicable for my study) -I have followed the relevant reporting for my study type, and included a populated checklist with my submission -Not applicable for my study
Replicated three times each experiment.
The results are expressed as mean ± standard error (SEM). GO and pathway enrichment analysis was done using Fisher's test, the smaller the P-value the greater the contact between the GO and pathway terms and the input differentially expressed genes. Two-sided P values <0.05 were considered statistically significant.
The data is consistent with the assumptions of the test. In addition, we estimated the variation of each set of data, and the results were similar to the differences between the groups that were statistically compared. This study was approved by the Ethics Committee of Beijing University of Chinese Medicine (BUCM) (2016BZHYLL0105). All enrolled patients were from hospitalized patients at the BUCM affiliated hospital and were confirmed to have signed informed consent after enrollment.
page 5 and 100-112 lines inserted
Resources
A description of all resources used should be included in the Methods section, with enough information to allow them to be uniquely identified. The table below should be completed with confirmation that this was done (i.e. included in the Methods section) or is not applicable. If this has not been completed, but is applicable, you should contact the journal editorial staff before proceeding.
Answer (page and line number inserted/Not applicable for my study)
•Antibodies: report source, catalogue code, characteristics, dilutions and how they were validated for the system under study.
•Cell lines: report source, whether identity has been authenticated and whether tested for mycoplasma contamination. We encourage researchers to check the NCBI database for contamination of cell lines.
•Organisms: report source, species, strain, sex, age, husbandry, inbred and strain characteristics of transgenic and mutant animals.
• 
